Our Facebook Group for the 108 Miles in September Challenge is officially OPEN ! This September, challenge yourself to raise money for prostate cancer research AND walk away with better health.
More info -
Register -
With humor and grace,
@daxshepard
takes a taboo subject that most men never want to think about and drives home the importance of understanding the risks and the tests available today for
#prostatecancer
.
#PCAM
#DoBlue
Love and best wishes to
@alroker
on a successful surgery and recovery next week. We are grateful for your partnership and leadership - even before your diagnosis – in raising awareness. Thank you for openly sharing your story so more men get checked & survive prostate cancer. 🙏🏼
Our TRUE campaign launches today and this year we are opening it up to everyone: prostate cancer caregivers, cancer caregivers, COVID caregivers (essential workers included).
Visit to share your story and be entered to receive a package from
@KristenBell
!
Men are much more open to discuss their health in a familiar environment. Dr. Frencher has found success talking to men at barber shops rather to encourage them to get screened.
Congratulations Jim Allison on winning the 2018
#NobelPrize
in Medicine! PCF was an early funder of Allison's
#immunotherapy
work in
#ProstateCancer
. Since then, 1000's of patients have been helped, and the promising fields of immunotherapy and precision medicine have ballooned.
Today,
@pcf
community mourns the loss of our inspiration, our leader, our chief. Don Coffey, your will always be with us as we continue your work to make sure that someday, no man dies of prostate cancer. "To strive, to seek, to find and not to yield."
#ourchief
@TODAYshow
Love and best wishes to
@alroker
on a successful surgery and recovery next week. We are grateful for your partnership and leadership - even before your diagnosis – in raising awareness. Thank you for openly sharing your story so more men get checked & survive prostate cancer. 🙏🏼
Every September, we observe Prostate Cancer Awareness Month in order to educate and convey the importance of men getting screened.
As we spread this knowledge, please share this potentially life-saving information with the men in your lives and stay tuned for updates this month!
Due to the pandemic we were unable to properly acknowledge the hard work and dedication of our Young Investigators for the past few years. Congratulations to all the 2020-2022 award recipients!
#pcfretreat22
#BREAKINGNEWS
Today, a revolutionary new type of prostate cancer scan was approved by the FDA. This new “PSMA PET” scan can detect prostate cancer metastases much earlier, which may help to improve treatment of patients with prostate cancer.
Read:
Exercise reduces the risk of dying of prostate cancer by 30 percent, and the risk of dying from any cause by 40 percent, says UCSF epidemiologist June Chan, Sc.D
The PCF Young Investigator Awards nurture and grow the future leaders in the field of
#prostatecancer
research.
They bring new ideas, new energy, and impact the prostate cancer field in innovative ways. 🔬Congratulations again 2023 Young Investigators!
Dr
@soulehoward1
has been a leader at PCF for over 25 years. His dedication to advancing
#prostatecancer
research and the mission of the Prostate Cancer Foundation cannot be understated.
This jacket is just a small token of our appreciation.
#thankyou
💙
Cancer takes a physical, emotional and financial toll.
@StaceyAbrams
recently spoke with us about her dad’s prostate cancer, the health disparity for African American men, and the importance of being a health activist.
#NationalMinorityHealthMonth
The PCF Young Investigator Awards offer career and project support for young proven investigators in postdoctoral fellowships or who have recently achieved junior faculty positions.
Congratulations to all our 2022 Award Winners! 🔬 🏆
The PCF Young Investigator Award represents our dedication to the future of prostate cancer research. Today, we're incredibly honored to announce the PCF Young Investigator Award Class of 2019 recipients!
It's
#PCFRetreat19
week!
This is our 26th Annual PCF Scientific Retreat and we're so excited to be bringing together the brightest minds in science to discuss the most significant & promising new
#prostatecancer
research.
Stay tuned to our pages for updates throughout!
Everyone's here for Day 2 of the 26th Annual PCF Scientific Retreat!
Today's schedule has been packed with incredible speakers and presentations, including a Keynote address from our Founder and Chairman Michael Milken. More to come!
#PCFRetreat19
Thank you
@NehaVapiwala
for kicking off our 8th Annual Women in Science Forum and being an incredible role model and inspiration to so many women.
#PCFRetreat23
New evidence-based PCF Prostate Cancer Screening Guidelines for Black Men in the U.S. recommend that Black men consider PSA screening between ages 40-45, and screen annually depending on PSA levels and health status. 🧵⬇️
The largest-ever genetic study of prostate cancer in Black men identified nine new gene variants that increase risk and determined polygenic risk score can predict more aggressive disease.
Breaking News: Today, a new treatment known as 177lutetium-PSMA-617 (Lu-PSMA; trade name PluvitcoTM) was approved by the FDA for certain patients with advanced prostate cancer. Read more:
Please pass along so all men know that prostate cancer:
1. Usually has NO early warning symptoms
2. But if detected early enough it is 99% curable
3. Getting a test is important and can be as simple as having a blood test.
We're excited to announce the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million in funding for innovative prostate cancer research.
Press release -
Projects-
#BREAKING
This has been a truly historic week, with two new treatment options receiving FDA approval for men with advanced prostate cancer. Today, olaparib was approved by the FDA for certain metastatic prostate cancers.
Today,
@PCFnews
and the
@Movember
Foundation announced three new Movember Foundation-PCF Challenge Awards! $2.5 million is being granted to teams at the world’s leading cancer research institutions to further support the goal of curing prostate cancer.
PCF congratulates Dr. Karen Knudsen (
@SKCCDirector
) who will be not only the first female leader of ACS (
@AmericanCancer
), but also the first cancer researcher to head the organization.
#BREAKING
Today, the
@US_FDA
has approved rucaparib, a new medication to treat some patients with advanced prostate cancer.
@PCF_Science
is proud to have been involved since the beginning, in every stage of the research that lead to this development.
Game-changer: FDA approved PyL PSMA PET scan which pinpoints location of
#prostate
cancer that has spread.
#PCF
’s 25-year
#PSMA
research investment is saving men’s lives.
“Prostate cancer has tragically affected my life. My stepfather recently passed away from late-stage disease & since we became aware of his diagnosis,
@IMKristenBell
& I have been doing whatever we can to support the great work that
@PCFNews
is doing..."
@daxshepard
Congratulations to our friend and PCF-funded researcher
@LoebStacy
on receiving the
@AmerUrological
Gold Cystoscope Award for her outstanding research enhancing the value of prostate cancer screening and active surveillance! 🙌
Since 1993 PCF has been responsible for raising more than $1 billion in support of cutting-edge research by more than 2,200 research projects at 245 leading cancer centers in 28 countries around the world.
We will not rest until we have found a cure -
There are several pros and cons to surgery vs radiation in regards to your quality of life. It's important to be informed of the potential side effects of each.
@dr_coops
provides a brief summary:
#BREAKING
: Last night, the U.S. Food and Drug Administration (
@US_FDA
) approved apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).
#HappyThanksgiving
! We are thankful to all the amazing
#prostatecancer
researchers, scientists & doctors who continue to work hard 4 better treatments for men with prostate cancer & their families. We are proud to fund their work & thankful for all our donors who make it happen!
PCF’s
@soulehoward1
and
@AndreaMiyahira
chair the Blue-Ribbon Science Review Committee that selects promising research to help men with prostate cancer.
Our grant process is unprecedented in thoroughness, as well as how fast we translate donations to treatments.
@PCF_Science
Together, Mike Milken &
@felixfengmd
of
@UCSF
have made a massive impact on the
#prostatecancer
community. Dr. Feng led foundational research on advanced prostate cancer as part of the West Coast Dream Team
Help us fund more life-saving research:
#BREAKING
: A PCF-funded study of men with prostate cancer in Italy suggests that men who were taking androgen deprivation therapy were 4 times less likely to be infected with the coronavirus than men who were not, and 5 times less likely to die.
Tomorrow is January 9th. We're calling it "1/9 Day" to highlight the 1 in 9 men who will be diagnosed with
#prostatecancer
in their lifetime. Send this to 9 men you know and have them do the same. Download our free Patient Guide for more.
#1in9Day
BREAKING NEWS! FDA approves
#enzalutamide
(Xtandi) for the treatment of non-metastatic castration-resistant
#prostatecancer
(non-metastatic CRPC). PCF funded the early research to synthesize this drug. Read more:
“Patients with
#ProstateCancer
should know about their family history with cancer,” says Dr. Heather Cheng, (
@HeatherHCheng
) assistant professor at The University of Washington-Seattle(
@UWMedicine
)
We're excited to see
@Seahawks
RB
@Prosisely_22
in these customized cleats during the game against the 49ers Sunday! It's all part of
@NFL
's "My Cause, My Cleats" campaign and they will be auctioned later, benefitting
@PCFnews
. Thanks NFL & CJ for their part in
#MyCauseMyCleats
!
Dr.
@EdwinPosadasMD
of
@CedarsSinai
discusses the impact of his Young Investigator Award achievement and what it can mean for future scientists.
Full interview:
COVID-19 is Tricky. But now we know it enters the lungs through a protein called TMPRSS2.
Since TMPRSS2 is testosterone driven, it could be why men are 2-3x more likely to die from it.
Can we use what we know to keep it from entering the lungs?
Read:
The whole
@PCFnews
team is ready & excited to raise money for men's health this
#Movember
with our partner
@movember
.
Grow the 'stache & join our team at or start your own team today at
Sadly, exercise is not on the radar for many men with prostate cancer, and it ought to be, because it extends life, improves quality of life, and slows the progression of prostate cancer.
There are some differences between surgery and radiation in regards to your quality of life. It's important to be informed of the potential side effects of each.
@dr_coops
provides a brief summary:
The(ProtecT) trial evaluated 82,429 men who underwent PSA testing between 1999 and 2009. The trial provides evidence that survival after PSA-detected prostate cancer is long, regardless of the patient-stratification method.
@urotoday
Don Coffey was a pioneer in the field of
#prostatecancer
research who leaves behind an indelible mark of progress in the world. "To strive, to seek, to find, and not to yield."
.
@Movember
starts tomorrow! Join us in changing the face of men’s health, raising funds and awareness for prostate cancer, testicular cancer, mental health and suicide prevention. Sign up or donate at
#Movember
Prostate cancer is heterogeneous - PSMA expression is no exception. Dr. Beltran's (
@mishabeltran
) research dives into the nuances for better patient care.
Watch the full discussion no
@urotoday
:
It is with heavy hearts that we share the passing of a good friend, esteemed colleague, and brilliant young cancer investigator, Brian Michael Olson. He will be dearly missed.
@urotoday
@charlesryanmd
@soulehoward1
@PCF_Science
It is with great sadness that we offer condolences on the sudden passing of Dr. Andrew Hruszkewycz of
@theNCI
on December 16th. Andrew was a friend and colleague to many at PCF, dedicated to the work of finding a cure for cancer, and he will be deeply missed.